CHAMPIONS ONCOLOGY, INC. Additional Paid in Capital, Common Stock
CHAMPIONS ONCOLOGY, INC. (CSBR) had Additional Paid in Capital, Common Stock of $86.08 million as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-09-11
- 2026-07-31: Additional Paid in Capital, Common Stock $86.08M.
- 2026-04-30: Additional Paid in Capital, Common Stock $85.70M.
- 2026-01-31: Additional Paid in Capital, Common Stock $85.38M.
- 2025-10-31: Additional Paid in Capital, Common Stock $84.98M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-07-31 | $86.08M 10-Q · filed 2026-09-11 | |
| 2026-04-30 | $85.70M 10-Q · filed 2026-09-11 | |
| 2026-01-31 | $85.38M 10-Q · filed 2026-03-12 | |
| 2025-10-31 | $84.98M 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $84.56M 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $84.36M 10-K · filed 2026-07-27 | |
| 2025-01-31 | $84.22M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $83.93M 10-Q · filed 2024-12-16 | |
| 2024-07-31 | $83.64M 10-Q · filed 2024-09-13 | |
| 2024-04-30 | $83.38M 10-K · filed 2025-07-23 | |
| 2024-01-31 | $83.12M 10-Q · filed 2024-03-15 | |
| 2023-10-31 | $82.74M 10-Q · filed 2023-12-13 | |
| 2023-07-31 | $82.45M 10-Q · filed 2023-09-13 | |
| 2023-04-30 | $82.01M 10-K · filed 2024-07-19 | |
| 2023-01-31 | $81.81M 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $81.47M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $81.27M 10-Q · filed 2022-09-12 | |
| 2022-04-30 | $81.06M 10-K · filed 2023-07-24 | |
| 2022-01-31 | $80.86M 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $80.48M 10-Q · filed 2021-12-13 | |
| 2021-07-31 | $80.23M 10-Q · filed 2021-09-13 | |
| 2021-04-30 | $79.94M 10-K · filed 2022-07-22 | |
| 2021-01-31 | $79.71M 10-Q · filed 2021-03-15 | |
| 2020-10-31 | $79.48M 10-Q · filed 2020-12-14 | |
| 2020-07-31 | $78.10M 10-Q · filed 2020-09-14 | |
| 2020-04-30 | $77.98M 10-K · filed 2021-07-26 | |
| 2020-01-31 | $73.79M 10-Q · filed 2020-03-16 | |
| 2019-10-31 | $73.13M 10-Q · filed 2019-12-16 | |
| 2019-07-31 | $73.06M 10-Q · filed 2019-09-16 | |
| 2019-04-30 | $72.92M 10-K · filed 2020-07-28 | |
| 2019-01-31 | $72.76M 10-Q · filed 2019-03-18 | |
| 2018-10-31 | $72.06M 10-Q · filed 2018-12-17 | |
| 2018-07-31 | $72.19M 10-Q · filed 2018-09-14 | |
| 2018-04-30 | $72.07M 10-K · filed 2019-07-29 | |
| 2018-01-31 | $71.91M 10-Q · filed 2018-03-19 | |
| 2017-10-31 | $71.73M 10-Q · filed 2017-12-15 | |
| 2017-07-31 | $71.56M 10-Q · filed 2017-09-14 | |
| 2017-04-30 | $70.99M 10-K · filed 2018-07-30 | |
| 2017-01-31 | $70.21M 10-Q · filed 2017-03-17 | |
| 2016-10-31 | $69.96M 10-Q · filed 2016-12-14 | |
| 2016-07-31 | $69.43M 10-Q · filed 2016-09-14 | |
| 2016-04-30 | $63.95M 10-K · filed 2017-07-28 | |
| 2016-01-31 | $63.39M 10-Q · filed 2016-03-16 | |
| 2015-10-31 | $62.83M 10-Q · filed 2015-12-15 | |
| 2015-07-31 | $62.08M 10-Q · filed 2015-09-11 | |
| 2015-04-30 | $61.32M 10-K · filed 2016-07-29 | $61.22M 10-K · filed 2015-07-29 |
| 2015-01-31 | $45.39M 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $44.89M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $44.07M 10-Q · filed 2014-09-12 | |
| 2014-04-30 | $43.26M 10-K · filed 2015-07-29 | |
| 2014-01-31 | $42.41M 10-Q · filed 2014-03-14 | |
| 2013-10-31 | $24.62M 10-Q · filed 2013-12-13 | |
| 2013-07-31 | $24.13M 10-Q · filed 2013-09-13 | |
| 2013-04-30 | $23.58M 10-K · filed 2014-07-28 | |
| 2013-01-31 | $23.14M 10-Q · filed 2013-03-13 | |
| 2012-10-31 | $22.57M 10-Q · filed 2012-12-13 | |
| 2012-07-31 | $21.94M 10-Q · filed 2012-09-12 | |
| 2012-04-30 | $21.20M 10-K · filed 2013-07-26 | |
| 2011-04-30 | $17.78M 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |